Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/30/2008 First Published: 10/31/2007


1.		Phase I/II Study of 3-Dimensional Conformal Radiotherapy, Intra- or Peri-Tumoral Injection of Poly ICLC With Trans-Hepatic Arterial Embolization Followed by Autologous Tumor Cell Vaccine Poly ICLC in Patients With Unresectable, Recurrent, or Metastatic Primary Hepatocellular or Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				UMDNJ-0120070076 0120070076, NCT00553683


2.		Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				05-115 RO1 NS055140, NCT00766753


3.		PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				NCI, Other				MCC-15262 USFIRB #106346, NCT00694551


4.		Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				Other				07-057 R21CA133859-01A1, NCT00795457

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute